Live Quote · NASDAQANABHealthcare· Biotechnology

AnaptysBio, Inc.

$46.63▼ 1.62%($-0.77)
MKT CAP $1.39BNEXT EARNINGS Mar 2, 2027
50%
Bullish
TickerSpark Score
69/100
▌ Solid
52
Valuation
100
Profitability
100
Growth
64
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANAB research report →

Analyst Price Target
$81.00+73.7% vs. today

Range $70 – $95

Analyst RatingBuy
17 Buy6 Hold0 Sell

Price Chart

+85.70% · this period
$69.81$47.46$25.11Nov 20May 26Nov 20
52-Week Range49% of range
Low
$22.07
Current
$46.63
High
$72.36